Other News

During 2018 EFNA continued to build on some of their ongoing projects – such as the MEP Interest Group on Brain, Mind and Pain and the Training Initiatives for Neurology Advocates.

European elections: developments in EU institutions Even though summer has arrived in Brussels, activities have not slowed down at EU level and there have been significant changes in leadership announced. Below is an overview of the main developments in the ‘EU Bubble’ following the EU Elections of last May

31 July 2019: Alzheimer Europe' adds new trials to its Clinical Trials Watch resource

In 2018, EBC launched a wide range of events, projects and advocacy initiatives aimed at promoting brain research and addressing the disease burden of mental and neurological conditions.

 “SILENTLY LOSING THE BRAIN – The enigma of small vessel disease” Come to Copenhagen for the next Brain Prize Meeting in November 2019. With international keynote speakers, including the 2019 prize winners, the Lundbeck Foundation Brain Prize Meeting aims to bring a broad range of researchers to discuss why small vessel disease has emerged as a major contributor to dementia, migraine and stroke worldwide.

The European Medicines Agency has recommended that the multiple sclerosis medicine Gilenya (fingolimod) must not be used in pregnant women and in women able to have children who are not using effective contraception. If a woman becomes pregnant while using Gilenya, the medicine must be stopped and the pregnancy will have to be closely monitored. This is because the active substance in Gilenya, fingolimod, can harm the unborn baby and may cause birth defects.

News from other societies

Ahead of discussions on the new Multiannual Financial Framework (EU Budget for 2021-2027) during the European Council Summit on 20-21 June, the BioMed Alliance together with the EU Health Coalition partners published a statement advocating for a more substantial EU research budget.

Early Bird rates for the 29th Alzheimer Europe Conference (#29AEC) closed on 30 June 2019. Alzheimer Europe is delighted to announce that almost 600 delegates have already registered, with many more expected between now and close of online registrations, on 13 October 2019. The number of registrations so far has exceeded all previous years. Alzheimer Europe is excited to see everyone there, for what promises to be a diverse and engaging conference.

In this article, our goal is to provide a glimpse into the excellent collaboration and cooperation our organization has had with the European Federation of Neurorehabilitation Societies (EFNR).

Science|Business is canvassing views on the big research priorities for the next term of the EU, from 2019 to 2024. Here, six policy experts discuss the most pressing items on the EU’s to-do list for health.

Neuronet Scientific Coordination Board meeting brings together project leaders from across the IMI neurodegenerative disease portfolio, encompassing EUR 260 million of funding

The #BrainLifeGoals campaign is an initiative of the European Federation of Neurological Associations that aims to raise awareness of the impact of neurological disorders.

Successful collaboration between the EAN and the International Neuro-urology Society (INUS) at the 7th annual International Neuro-urology Meeting in Zurich. The 7th International Neuro-urology Meeting was held in January 2019 and for the first time, a dedicated Neurosciences workshop was held in collaboration with the EAN. The half-day workshop on Thursday 24 January 2019 began with imaging research and our understanding of the neural control of the lower urinary tract, and included topics such as a review of the neural networks responsible for lower urinary tract control, potential brain imaging biomarkers to evaluate therapeutic interventions for LUT dysfunction and Neuroimaging of functional recovery in SCI. 

Interview with Prof. Claudio Baracchini - President of the ESNCH Prof. Dafin Muresanu interviews President of the ESNCH, Prof. Claudio Baracchini